TAHO Pharmaceuticals

• NCT06689436

  Phase 2, Completed, 60 people, 14 Nov 2024

• Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers

  Early phase 1, Completed, 12 people, 16 Aug 2023

Sources: clinicaltrials.gov